Modèle BioRender

Chemogenetics in the Treatment of Stroke

Créé par

Edoardo Alfì

•

BioRender Team

Utiliser ce modèle – Gratuit

Aucune carte de crédit requise pour l'inscription.

Ce modèle est entièrement modifiable dans BioRender

Remplacez le texte, les formes et les icônes
Changez les couleurs et réorganisez chaque icône, ligne et étiquette
Exportez ou partagez pour tout type d'utilisation

Rejoignez plus de 4 millions de scientifiques qui créent déjà des figures prêtes pour la publication

Description: This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication. This figure summarizes the findings from Wang et al. (2020). The group found that the Cre-mediated expression of hM4Di, a Designer Receptors Exclusively Activated by Designer Drugs (DREADD)-based chemogenetic receptor, inhibits the activity of forebrain excitatory neurons and leads to improved stroke outcome.

Les icônes et modèles BioRender respectent les normes des revues, des subventions et du droit d'auteur. Pour les figures générées par IA, les politiques varient. En savoir plus

Ce n'est pas tout à fait le bon modèle ? Découvrez-en plus.

Recherchez parmi des milliers de modèles dans plus de 30 domaines des sciences de la vie.

Sujets populaires :

Cell

Cancer

Administration de médicaments

Mécanisme d'action

Voie métabolique

Essayez un synonyme ou inscrivez-vous pour suggérer un modèle depuis l'application.

Nouveaux modèles

Kidney Reabsorption and Secretion

Alzheimer's Brain (Disintegrating Microtubule)

Favipiravir: Potential Repurposed Drug Candidate for COVID-19

Schematic of Spike-Receptor Binding Mechanism of SARS-CoV-2

Arabidopsis Rosette Mutants

Amplification of DNA Fragments Inserted into a Plasmid

Virtual Background - Night City

Periodic Table 2 Thank You E-Card

FAQ sur les modèles BioRender

What does the Chemogenetics in the Treatment of Stroke template show?

This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication. This figure summarizes the findings from Wang et al. (2020). The group found that the Cre-mediated expression of hM4Di, a Designer Receptors Exclusively Activated by Designer Drugs (DREADD)-based chemogenetic receptor, inhibits the activity of forebrain excitatory neurons and leads to improved stroke outcome.

Is the Chemogenetics in the Treatment of Stroke template free to use?

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Can I edit or customize this template?

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Is this template accepted for use in journals, theses, or grant applications?

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

How do I cite BioRender if I use this template?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

What is Chemogenetics in the Treatment of Stroke used for / who typically uses this template?

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.